Par Drugs & Chemicals Ltd Declines 3.07%: 3 Key Events Shaping the Week

15 September 2026: Sharp Decline to Lower Circuit Amid Heavy Selling

Par Drugs & Chemicals Ltd opened the week on a weak note, plunging 5.00% to close at Rs.133.88, hitting the lower circuit limit. The stock faced intense selling pressure, with a maximum intraday drop of Rs.7.04. This decline was sharper than the Sensex’s 1.69% fall, signalling stock-specific weakness. The Chemicals & Petrochemicals sector also declined by 3.64%, but Par Drugs & Chemicals underperformed even this sector benchmark.

Trading volume was moderate at 26,115 shares, reflecting concentrated selling activity. Despite the sharp fall, the stock remained above its longer-term moving averages, suggesting the sell-off was a short-term correction rather than a fundamental breakdown. However, the breach below the 5-day moving average indicated immediate bearish momentum. The downgrade of the Mojo Grade to Hold on 26 August 2026 likely contributed to the cautious investor sentiment.

16 September 2026: Continued Selling Pressure Triggers Second Lower Circuit

The downward momentum persisted on 16 September, with the stock again hitting the lower circuit limit of 5%, closing at Rs.127.19. This represented a further 5.00% decline, significantly underperforming the Chemicals & Petrochemicals sector’s 1.92% fall and contrasting with the Sensex’s marginal 0.07% gain. The stock’s micro-cap status and limited liquidity exacerbated the price volatility, as modest volumes of 19,322 shares were sufficient to push the price down sharply.

Technically, the stock remained above its medium- and long-term moving averages but stayed below the 5-day average, reinforcing the short-term bearish trend. The persistent unfilled supply at lower price levels reflected a lack of buyer interest, intensifying the selling pressure. The downgrade to Hold and the micro-cap classification heightened risk perceptions among investors, contributing to the panic selling.

17 September 2026: Strong Rebound with Upper Circuit Surge

In a dramatic turnaround, Par Drugs & Chemicals Ltd surged 4.99% to hit the upper circuit limit at Rs.133.54 on 17 September. This rally outpaced the Chemicals & Petrochemicals sector’s 0.85% gain and the Sensex’s 0.60% rise, signalling renewed buying interest and a shift in market sentiment. The stock’s intraday range was wide, with a low of Rs.121.06, reflecting significant volatility but sustained upward momentum.

Volume increased to 32,085 shares, supporting the strong price move. The upper circuit hit indicated unfilled demand and robust buying pressure, often a sign of positive sentiment or speculative interest in micro-cap stocks. The stock remained above all key moving averages, confirming a healthy medium- to long-term uptrend despite recent volatility. However, the recent downgrade to Hold suggests investors remain cautious about the sustainability of this rally.

Sectoral resilience amid fluctuating raw material costs and regulatory changes may have contributed to the stock’s relative strength. The micro-cap nature of the company means such sharp moves are not uncommon, driven by liquidity constraints and concentrated trading activity.

18 September 2026: Continued Gains Amid Positive Market Momentum

Par Drugs & Chemicals Ltd extended its gains on 18 September, closing at Rs.136.60, up 2.29%. This performance outpaced the Sensex’s 0.52% rise, indicating sustained investor interest following the previous day’s surge. Trading volume remained healthy at 29,278 shares, supporting the upward price movement. The stock’s recovery from the earlier lower circuit hits highlights the volatile nature of micro-cap stocks and the rapid shifts in investor sentiment.

Despite the week’s overall 3.07% decline from Rs.140.92, the late-week rebound suggests some stabilisation. The stock’s Mojo Score of 68.0 and Hold rating reflect moderate confidence but also caution, underscoring the need for investors to monitor developments closely.

Daily Price Performance: Par Drugs & Chemicals Ltd vs Sensex

Key Takeaways

Volatility and Circuit Hits: The stock’s two consecutive lower circuit hits on 15 and 16 September highlight intense selling pressure and panic among investors, exacerbated by the stock’s micro-cap status and limited liquidity. Such volatility is typical for smaller stocks but signals caution.

Technical Support and Recovery: Despite sharp declines, the stock remained above its medium- and long-term moving averages, indicating underlying technical support. The upper circuit surge on 17 September and continued gains on 18 September suggest a potential short-term recovery or consolidation phase.

Rating and Sentiment: The downgrade to a Hold rating and a Mojo Score of 68.0 reflect moderate confidence but increased caution. This rating adjustment likely influenced investor behaviour, contributing to the initial sell-off and subsequent volatility.

Sector and Market Context: The Chemicals & Petrochemicals sector showed mixed performance during the week, with the stock underperforming on down days and outperforming on the rebound. The broader Sensex remained relatively stable, underscoring the stock-specific nature of the price swings.

Liquidity Constraints: The micro-cap classification and modest trading volumes amplify price swings and can lead to exaggerated moves on relatively low volumes, necessitating careful risk management for investors.

Conclusion

Par Drugs & Chemicals Ltd’s week was marked by significant price swings, with two lower circuit hits followed by a strong rebound capped by an upper circuit surge. The stock’s 3.07% weekly decline contrasts with the Sensex’s modest 0.41% fall, reflecting company-specific challenges and investor caution. While technical indicators provide some support, the downgrade to Hold and micro-cap volatility warrant a prudent approach. Investors should closely monitor upcoming corporate developments and sector trends to navigate the stock’s dynamic price action effectively.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →